{{The FDA disagrees with you and so do I. The FDA approved Phase III and Sunrise was given FastTrack. Also... the FDA and Peregrine has learned much more regarding their trials and a BLA filing with over 100,000 pages filed many months ago. We will not hear about the rest until a later time.}}
Fast Track is irrelevant. The trial was stopped at the first futility analysis. PPHM said the trial has bend discontinued. There is nothing to debate and nothing is in dispute. The trial is dead. That means the decision by PPHM to move forward in the phase III trial was a mistake and a poor use of money. Why can't you accept reality?
{{You were not proven correct as you seem to be ignorant of the facts of the reasons why Sunrise was stopped. Name 1 trial that a Docetaxel arm exceeded historic norms and the respective biotech drug arm going up against Docetaxel "performed as expected..". Once some light is shed further on those details, then are proven wrong again.}}
Stop quoting the exceeded all historical norms comment as if it were fact. It is not. You haven't seen the data and PPHM hasn't released the data. The press release on the PPHM web site doesn't say that either. Even if it were true, it is irrelevant to Sunrise. That is dead.
Market Data 
Markets 
AI
